- $6.98bn
- $6.65bn
- $837.55m
- 88
- 10
- 67
- 55
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 726 | 811 | 1,037 | 1,006 | 838 |
Cost of Revenue | |||||
Gross Profit | 536 | 605 | 760 | 722 | 601 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 583 | 640 | 722 | 760 | 707 |
Operating Profit | 143 | 171 | 315 | 246 | 131 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 163 | 187 | 319 | 251 | 135 |
Provision for Income Taxes | |||||
Net Income After Taxes | 204 | 176 | 280 | 216 | 113 |
Net Income Before Extraordinary Items | |||||
Net Income | 204 | 176 | 280 | 216 | 113 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 204 | 176 | 280 | 216 | 113 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.16 | 1.19 | 1.56 | 1.34 | 0.616 |
Dividends per Share | |||||
Special Dividends per Share |